Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $86.9800 (0.3%) ($86.7800 - $87.7100) on Fri. Dec. 6, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.29% (three month average) | RSI | 42 | Latest Price | $86.9800(0.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.2% a day on average for past five trading days. | Weekly Trend | ABBV declines -0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(64%) SPLV(53%) VYM(53%) DIA(52%) IVE(52%) | Factors Impacting ABBV price | ABBV will decline at least -0.645% in a week (0% probabilities). VIXM(-36%) TLT(-15%) VXX(-14%) IGOV(-4%) UUP(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.645% (StdDev 1.29%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
Resistance Level | $87.17 | 5 Day Moving Average | $86.78(0.23%) | 10 Day Moving Average | $87.14(-0.18%) | 20 Day Moving Average | $87.17(-0.22%) | To recent high | -2.3% | To recent low | 30.4% | Market Cap | $153.457b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |